Your browser doesn't support javascript.
loading
Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.
Jegaskanda, S; Ahn, S H; Skinner, N; Thompson, A J; Ngyuen, T; Holmes, J; De Rose, R; Navis, M; Winnall, W R; Kramski, M; Bernardi, G; Bayliss, J; Colledge, D; Sozzi, V; Visvanathan, K; Locarnini, S A; Kent, S J; Revill, P A.
Afiliação
  • Jegaskanda S; Department of Microbiology and Immunology, Peter Doherty Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Ahn SH; Division of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute, Parkville, Victoria, Australia Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Skinner N; Department of Medicine, Eastern Hill Academic Centre, The University of Melbourne, Parkville, Victoria, Australia Department of Infectious Diseases, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
  • Thompson AJ; Division of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute, Parkville, Victoria, Australia Department of Gastroenterology, St. Vincent's Hospital, Fitzroy, Victoria, Australia Department of Medicine, Eastern Hill Academic Centre, The U
  • Ngyuen T; Division of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute, Parkville, Victoria, Australia Department of Gastroenterology, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
  • Holmes J; Division of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute, Parkville, Victoria, Australia Department of Gastroenterology, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
  • De Rose R; Department of Microbiology and Immunology, Peter Doherty Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Navis M; Department of Microbiology and Immunology, Peter Doherty Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Winnall WR; Department of Microbiology and Immunology, Peter Doherty Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Kramski M; Department of Microbiology and Immunology, Peter Doherty Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Bernardi G; Department of Microbiology and Immunology, Peter Doherty Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Bayliss J; Division of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute, Parkville, Victoria, Australia.
  • Colledge D; Division of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute, Parkville, Victoria, Australia.
  • Sozzi V; Division of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute, Parkville, Victoria, Australia.
  • Visvanathan K; Department of Medicine, Eastern Hill Academic Centre, The University of Melbourne, Parkville, Victoria, Australia Department of Infectious Diseases, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
  • Locarnini SA; Division of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute, Parkville, Victoria, Australia.
  • Kent SJ; Department of Microbiology and Immunology, Peter Doherty Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Revill PA; Department of Microbiology and Immunology, Peter Doherty Institute, The University of Melbourne, Parkville, Victoria, Australia Division of Research and Molecular Development, Victorian Infectious Diseases Reference Laboratory, Peter Doherty Institute, Parkville, Victoria, Australia peter.revill@mh.
J Virol ; 88(18): 10412-20, 2014 Sep.
Article em En | MEDLINE | ID: mdl-24872585

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulação para Baixo / Vírus da Hepatite B / Interferon gama / Interleucina-18 / Hepatite B / Antígenos E da Hepatite B Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Virol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulação para Baixo / Vírus da Hepatite B / Interferon gama / Interleucina-18 / Hepatite B / Antígenos E da Hepatite B Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Virol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Austrália